[The recent advance of treatment of Parkinson's disease].

Abstract	The primary pathology of Parkinson's disease is the degeneration of dopaminergic neurons in the nigrostriatal pathway, resulting in a significant reduction in striatum dopamine concentration which is responsible for the altered motor functions. With time and disease progression, efficacy of dopaminergic therapy becomes unpromising. We herein review the recent advance of treatment of Parkinson's disease to prevent ongoing progressive nature of Parkinson's disease.
Authors	Etsuro Matsubara
Journal	Nihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 62 Issue 9 Pg. 1725-8 (Sep 2004) ISSN: 0047-1852 [Print] Japan
PMID	15462392 (Publication Type: English Abstract, Journal Article, Review)
Chemical References	Antiparkinson Agents
Topics	Antiparkinson Agents (therapeutic use) Humans Parkinson Disease (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!